OS Therapies Incorporated (OSTX)

OS Therapies (OSTX) CEO discusses novel HER2-targeted immunotherapy for osteosarcoma on Cell & Gene podcast, following positive Phase 2B trial results and FDA filing progress.

About OS Therapies Incorporated

OS Therapies Incorporated is a biotechnology company focused on developing novel therapies for cancer treatment.
OS Therapies Incorporated uses the ticker $OSTX for trading. Listed in the Stocks category.

Insights

• OS Therapies Incorporated (OSTX) mentions hit [--] which is 126% higher than it's daily average.
• OS Therapies Incorporated (OSTX) social dominance is up 562.5% from the previous [--] months.
• OS Therapies Incorporated (OSTX) creators is up 12.28% from the previous week.
• OS Therapies Incorporated (OSTX) engagements is up 49.58% from the previous week.
• OS Therapies Incorporated (OSTX) mentions is up 10.97% from the previous week.
• OS Therapies Incorporated (OSTX) posts created is up 20% from the previous week.

Price: $1.20

Price 24-Hour Time-Series Raw Data
The stock price is driven by positive clinical trial results and FDA filing progress, leading to a 52-week high, though a slight 24-hour dip suggests potential profit-taking.

24-Hour: 5.17% 7-Day: -12.86% 30-Day: -16.44%

1-Year High: $2.50 on 2025-08-27
1-Year Low: $1.20 on 2026-02-12

AltRank: [-----]

AltRank 24-Hour Time-Series Raw Data
OS Therapies Incorporated (OSTX) is currently AltRank #1,712 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] [----]
1-Year High: [-----] on 2026-02-11
1-Year Low: [---] on 2026-01-25

Galaxy Score: [-----]

Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
1-Year High: [--] on 2026-01-26
1-Year Low: [--] on 2026-01-30

Engagements: [---] (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-----] +50%
[--] Month: [------] -22%
[--] Months: [-------] -26%
[--] Year: [---------] +8.90%
1-Year High: [------] on 2025-02-18
1-Year Low: [--] on 2025-05-09

Engagements by network (24h): Reddit: [--] X: [---] TikTok: [--] YouTube: [--]

Mentions: [--] (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] +11%
1-Year High: [---] on 2025-07-04
1-Year Low: [--] on 2025-05-09

Mentions by network (24h): Reddit: [--] X: [--] TikTok: [--] YouTube: [--]

Creators: [--] (24h)

Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning OS Therapies Incorporated (OSTX) in the last [--] hours which is up 48% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +12%
1-Year High: [---] on 2025-07-17
1-Year Low: [--] on 2025-05-09

Sentiment: 94%

Sentiment 24-Hour Time-Series Raw Data
Current Value: 94%
Daily Average: 92%
[--] Week: 100% no change
[--] Month: 92% no change
[--] Months: 92% +21%
[--] Year: 92% +23%
1-Year High: 100% on 2025-02-20
1-Year Low: 33% on 2025-03-17

Most Supportive Themes:

• Positive Clinical Trial Results: (70%) OS Therapies Incorporated (OSTX) has announced positive clinical trial results for its OST-HER2 therapy, showing a significant benefit in preventing or delaying recurrent pulmonary metastatic osteosarcoma.
• FDA Filing and Review Process: (20%) The company has initiated the US FDA Biologics License Application (BLA) filing for OST-HER2 and is engaging in discussions with the FDA regarding biomarker data, indicating progress in the regulatory pathway.

Most Critical Themes:

• Market Volatility and Profit-Taking: (15%) Despite positive news, the stock experienced a slight 24-hour dip, suggesting potential profit-taking or short-term market fluctuations that could impact the stock price.

Social Dominance: 0.00526%

Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00526%
Daily Average: 0.00464%
[--] Week: 0.00553% +0.00453%
[--] Month: 0.0053% +0.0007000000000000001%
[--] Months: 0.0053% +0.0024%
[--] Year: 0.0053% -0.026%
1-Year High: 0.04% on 2025-07-04
1-Year Low: 0.0001% on 2025-10-05

Market Dominance: 0.00004866560114447291%

Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00004866560114447291%
Daily Average: 0%
1-Year High: 0.00006% on 2026-01-13
1-Year Low: 0.00005% on 2026-02-04

Market Cap: $42,961,509

Market Cap 24-Hour Time-Series Raw Data
Current Value: $42,961,509
Daily Average: $48,646,112
[--] Week: $43,313,653 -6.80%
[--] Month: $42,961,509 -16%
1-Year High: $54,582,246 on 2026-01-14
1-Year Low: $40,848,648 on 2026-02-12

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing